Earnings call transcript: BioCardia posts q2 2026 loss beat, shares rise after hours
BioCardia (BCDA) reported a smaller-than-expected Q2 2026 loss of $0.13 per share, beating analyst estimates of $0.18, and its shares rose in after-hours trading. The company highlighted significant regulatory progress, including support from Japan's PMDA for a Shonin submission for CardiAMP cell therapy and …